368 related articles for article (PubMed ID: 15713751)
1. Cadherin switching: essential for behavioral but not morphological changes during an epithelium-to-mesenchyme transition.
Maeda M; Johnson KR; Wheelock MJ
J Cell Sci; 2005 Mar; 118(Pt 5):873-87. PubMed ID: 15713751
[TBL] [Abstract][Full Text] [Related]
2. c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation.
Jenndahl LE; Isakson P; Baeckström D
Int J Oncol; 2005 Aug; 27(2):439-48. PubMed ID: 16010426
[TBL] [Abstract][Full Text] [Related]
3. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
4. Id-1 promotes TGF-beta1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells.
Di K; Wong YC; Wang X
Exp Cell Res; 2007 Nov; 313(19):3983-99. PubMed ID: 17916352
[TBL] [Abstract][Full Text] [Related]
5. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
Kasai H; Allen JT; Mason RM; Kamimura T; Zhang Z
Respir Res; 2005 Jun; 6(1):56. PubMed ID: 15946381
[TBL] [Abstract][Full Text] [Related]
6. N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma.
Nakajima S; Doi R; Toyoda E; Tsuji S; Wada M; Koizumi M; Tulachan SS; Ito D; Kami K; Mori T; Kawaguchi Y; Fujimoto K; Hosotani R; Imamura M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4125-33. PubMed ID: 15217949
[TBL] [Abstract][Full Text] [Related]
7. [Effect of Smad7 on transforming growth factor-beta1-induced alveolar epithelial to mesenchymal transition].
Xu GP; Li QQ; Cao XX; Chen Q; Zhao ZH; Diao ZQ; Xu ZD
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1918-23. PubMed ID: 17923018
[TBL] [Abstract][Full Text] [Related]
8. Ferritin heavy chain-mediated iron homeostasis and subsequent increased reactive oxygen species production are essential for epithelial-mesenchymal transition.
Zhang KH; Tian HY; Gao X; Lei WW; Hu Y; Wang DM; Pan XC; Yu ML; Xu GJ; Zhao FK; Song JG
Cancer Res; 2009 Jul; 69(13):5340-8. PubMed ID: 19531652
[TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 causes epithelial-mesenchymal transition in HaCaT derivatives, but induces expression of COX-2 and migration only in benign, not in malignant keratinocytes.
Räsänen K; Vaheri A
J Dermatol Sci; 2010 May; 58(2):97-104. PubMed ID: 20399617
[TBL] [Abstract][Full Text] [Related]
10. Decreased expression of glutaredoxin 1 is required for transforming growth factor-beta1-mediated epithelial-mesenchymal transition of EpRas mammary epithelial cells.
Lee EK; Jeon WK; Chae MY; Hong HY; Lee YS; Kim JH; Kwon JY; Kim BC; Park SH
Biochem Biophys Res Commun; 2010 Jan; 391(1):1021-7. PubMed ID: 19968960
[TBL] [Abstract][Full Text] [Related]
11. Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin.
Janda E; Nevolo M; Lehmann K; Downward J; Beug H; Grieco M
Oncogene; 2006 Nov; 25(54):7117-30. PubMed ID: 16751808
[TBL] [Abstract][Full Text] [Related]
12. Modulation of ezrin and E-cadherin expression by IL-1beta and TGF-beta1 in human trophoblasts.
Karmakar S; Das C
J Reprod Immunol; 2004 Dec; 64(1-2):9-29. PubMed ID: 15596224
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
Yoshikawa M; Hishikawa K; Marumo T; Fujita T
J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397
[TBL] [Abstract][Full Text] [Related]
14. Nuclear factor-kappaB-mediated transforming growth factor-beta-induced expression of vimentin is an independent predictor of biochemical recurrence after radical prostatectomy.
Zhang Q; Helfand BT; Jang TL; Zhu LJ; Chen L; Yang XJ; Kozlowski J; Smith N; Kundu SD; Yang G; Raji AA; Javonovic B; Pins M; Lindholm P; Guo Y; Catalona WJ; Lee C
Clin Cancer Res; 2009 May; 15(10):3557-67. PubMed ID: 19447876
[TBL] [Abstract][Full Text] [Related]
15. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression.
Gordon KJ; Dong M; Chislock EM; Fields TA; Blobe GC
Carcinogenesis; 2008 Feb; 29(2):252-62. PubMed ID: 17999987
[TBL] [Abstract][Full Text] [Related]
16. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells.
Shtutman M; Levina E; Ohouo P; Baig M; Roninson IB
Cancer Res; 2006 Dec; 66(23):11370-80. PubMed ID: 17145883
[TBL] [Abstract][Full Text] [Related]
17. Gain of oncogenic function of p53 mutants regulates E-cadherin expression uncoupled from cell invasion in colon cancer cells.
Roger L; Jullien L; Gire V; Roux P
J Cell Sci; 2010 Apr; 123(Pt 8):1295-305. PubMed ID: 20332115
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling of a TGF-beta-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies.
Lenferink AE; Cantin C; Nantel A; Wang E; Durocher Y; Banville M; Paul-Roc B; Marcil A; Wilson MR; O'Connor-McCourt MD
Oncogene; 2010 Feb; 29(6):831-44. PubMed ID: 19935703
[TBL] [Abstract][Full Text] [Related]
19. PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase.
Li Y; Dai C; Wu C; Liu Y
J Am Soc Nephrol; 2007 Sep; 18(9):2534-43. PubMed ID: 17656471
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells.
Lindley LE; Briegel KJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):659-64. PubMed ID: 20691661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
